Pine Labs financials

·Banking & FinanceChart ›
Latest results Q2 FY27 · Jul–Sep 2026
Revenue
₹806cr+24.0% on Q2 FY26
Net profit
₹38.6cr+546.1% on Q2 FY26
EBITDA margin
15.6%+4.0 pts on Q2 FY26
EPS
₹0.33+450.0% on Q2 FY26

Quarterly results

Every quarter ›
₹ croreQ2 FY27Q2 FY26Change
Revenue806650+24.0%
EBITDA12675.4+67.1%
EBITDA margin15.6%11.6%+4.0 pts
Profit before tax61.411.2+446.5%
Net profit38.66.0+546.1%
EPS₹0.33₹0.06+450.0%

Over time

Q2 FY27 · Jul–Sep 2026latest
Revenue₹806 crNet profit₹38.6 crNet margin4.8%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026
18,856—
1,3491,393
283283
17,790—
2,9882,711
459358
15.4%13.2%
17188.4
160113
5.4%4.2%
₹1.39₹0.98
—395
—−238
157157
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

PINELABS₹164.21

Pine Labs Ltd.

· Banking & Finance
₹ CrorePeersPAYTMNUVAMASTARHEALTHJMFINANCILUCOBANKIOBIFCIAADHARHFCMcap ₹18,856 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization—18,856.2
- Cash, Equiv & ST Investments1,393.11,348.7
+ Total Debt282.9282.9
Enterprise Value—17,790.5
Revenue2,710.62,987.9
EBITDA358.5459.3
Margin %13.2315.37
EBIT88.4171.0
Net Income112.5159.9
Margin %4.155.35
EPS, Adj (current shares)0.981.39
Cash from Operations395.4—
Capital Expenditures-238.4—
Free Cash Flow157.0157.0
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Pine Labs financials and key ratios

Prices at the 29 October 2026 close · figures from the company's filings with NSE

Pine Labs (NSE: PINELABS) had a market capitalisation of ₹17,696 crore at the 29 October 2026 close (₹153.25 a share), a PE ratio of 110.7 on the last four quarters' profit and a price-to-book ratio of 2.94. In FY26 its consolidated net profit was ₹113 crore on revenue of ₹2,711 crore; in Q2 FY27 (July–September 2026) it was ₹38.6 crore, up 546.1% year on year. Its debt-to-equity ratio was 0.03 on 30 September 2026.

Pine Labs Q2 FY27 results
filed 29 October 2026
Share price used
₹153.25 · 29 October 2026 close
Latest balance sheet
30 September 2026
Shareholding pattern
30 September 2026

Pine Labs at a glance · consolidated

Market cap
₹17,696 Crat ₹153.25 · 29 Oct close
PE ratio (last 4 quarters)
110.7157.3 on FY26 profit
Price to book (PB)
2.94book value ₹52.13 a share
Debt to equity
0.03net cash ₹8,357 Cr
FII holding
13.18%+3.7 pts vs 30 Jun 2026no promoter group
Net worth
₹6,019 Cr+62.2% vs 30 Sep 202530 September 2026

Questions

What is the Pine Labs PE ratio today?

Pine Labs' PE ratio is 110.7 at the 29 October 2026 close (₹153.25 a share): a market capitalisation of ₹17,696 crore divided by consolidated net profit of ₹160 crore over the last four quarters (Q3 FY26 to Q2 FY27). On FY26 net profit (₹113 crore) it is 157.3.

What is the Pine Labs PB ratio (price to book value)?

Pine Labs' price-to-book (PB) ratio is 2.94 at the 29 October 2026 close: a market capitalisation of ₹17,696 crore divided by shareholders' equity (book value) of ₹6,019 crore on 30 September 2026. That is a book value of ₹52.13 per share against a share price of ₹153.25.

What is the Pine Labs net worth?

Pine Labs' net worth — shareholders' equity in its consolidated balance sheet — was ₹6,019 crore on 30 September 2026, up 62.2% from ₹3,711 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹17,696 crore at the 29 October 2026 close.

What is the Pine Labs market cap?

Pine Labs' market capitalisation was ₹17,696 crore at the 29 October 2026 close: 115.47 crore shares at ₹153.25 each.

Is Pine Labs debt free?

No. Pine Labs had borrowings of ₹183 crore on 30 September 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.03. Its cash and current investments were ₹8,540 crore, so it held net cash of ₹8,357 crore.

What is the Pine Labs debt to equity ratio?

Pine Labs' debt-to-equity ratio was 0.03 on 30 September 2026: borrowings of ₹183 crore against total equity of ₹6,019 crore. A year earlier, on 30 September 2025, it was 0.20.

What is the Pine Labs book value per share?

Pine Labs' book value per share was ₹52.13 on 30 September 2026: shareholders' equity of ₹6,019 crore divided by the 115.47 crore shares in issue. The share price at the 29 October 2026 close was ₹153.25.

What is the Pine Labs promoter holding?

Pine Labs has no promoter group: on 30 September 2026 promoters held 0% of its shares, according to the shareholding pattern filed with NSE. Foreign portfolio investors held 13.18% and domestic institutions 29.58%.

What is the Pine Labs free cash flow?

In FY26, Pine Labs generated ₹395 crore of cash from operations and spent ₹238 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹157 crore.

What is the Pine Labs EPS?

Pine Labs' basic earnings per share (EPS) were ₹1.05 in FY26.

What is the Pine Labs revenue and profit in FY26?

In FY26 (April 2025–March 2026), Pine Labs' consolidated net profit was ₹113 crore, on revenue from operations of ₹2,711 crore.

When are the Pine Labs next results?

Pine Labs has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.

What is the Pine Labs shareholding pattern?

On 30 September 2026, Pine Labs' shares were held by foreign portfolio investors (FII/FPI) 13.18%, domestic institutions (DII) 29.58% (including mutual funds at 26.69%) and retail and other non-institutional investors 57.24%.

What are the Pine Labs latest quarterly results?

Pine Labs' latest results are for Q2 FY27 (July–September 2026), filed on 29 October 2026: consolidated net profit ₹38.6 crore, up 546.1% from ₹6 crore in Q2 FY26; revenue from operations ₹806 crore, up 24.0% year on year.

How does the Pine Labs PE ratio compare with its peers?

At the 29 October 2026 closing prices, on FY26 net profit, Pine Labs' PE ratio is 157.3, the second highest of the four: Paytm 189.1, Nuvama Wealth Management 30.4 and Star Health and Allied Insurance 56.0, a peer average of 91.9. Each is the company's market capitalisation at that price divided by its FY26 net profit.

Pine Labs vs Paytm: how do they compare?

In FY26, Pine Labs earned net profit of ₹113 crore on revenue of ₹2,711 crore, against ₹553 crore on ₹8,437 crore for Paytm. Pine Labs' operating margin was 3.3% (Paytm −0.8%). At the 29 October 2026 close, Pine Labs' market capitalisation was ₹17,696 crore against ₹1,04,595 crore for Paytm, and its PE ratio on FY26 profit 157.3 against 189.1.

Where do these Pine Labs figures come from?

From Pine Labs' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.